3421. Dificlir-EMEA-H-C-2087-PSUV-0015: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3422. Rebetol-H-C-PSUSA-10007-201307 3423. Effentora-H-C-PSUSA-00001369-201304 3424. Eliquis-H-C-PSUSA-226-201605: Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s) 3425. Cialis-H-C-PSUSA-00002841-201510 3426. Optaflu-H-C-PSUSA-00001745-201504 3427. Adenuric-H-C-777-PSUV-0033 3428. Xgeva-PSUSA-00009119-201609 3429. Targretin-H-C-PSUSA-00000404-201409 3430. Harvoni-PSUSA-00010306-201510 3431. Jalra-H-C-PSUSA-00003113-201502 3432. Protopic-H-C-374-PSUSA-00002840-201503 3433. ViraferonPeg-H-C-329-PSUV-0110: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3434. Alprolix-H-C-PSUSA-00010499-201803 3435. Lumigan-H-C-PSUSA-00000413-201503 3436. Myfenax-PSUSA-00010550-201705 3437. Protelos-H-C-560-PSUV-0042 3438. Exjade-H-C-PSUSA-00000939-201410 3439. Ketoconazole HRA-H-C-PSUSA-00010316-201605 3440. Cinryze-H-C-1207-PSUV-0023 3441. Revolade-H-C-PSUSA-00001205-201609 3442. Jakavi-H-C-PSUSA-00010015-201702 3443. Tracleer-H-C-PSUSA-00000425-201411 3444. Zinforo-H-C-PSUSA-00010013-201504 3445. Desloratadine ratiopharm-H-C-PSUSA-962-201607 3446. Pantoloc Control-H-C-PSUSA-00002285-201708 3447. Fycompa-H-C-2434-PSUV-0009 3448. Ivemend-H-C-PSUSA-1471-201603: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3449. Viekirax-H-C-PSUSA-00010367-201507 3450. Aubagio-H-C-2514-PSUV-0005